| Literature DB >> 28050151 |
D Bossé1, T Ng1, C Ahmad2, A Alfakeeh3, I Alruzug3, J Biagi1, J Brierley1, P Chaudhury3, S Cleary1, B Colwell4, C Cripps1, L A Dawson1, M Dorreen4, E Ferland3, P Galiatsatos3, S Girard3, S Gray5, F Halwani1, N Kopek3, A Mahmud1, G Martel1, L Robillard1, B Samson3, M Seal2, J Siddiqui2, L Sideris3, S Snow4, M Thirwell3, M Vickers1, R Goodwin1, R Goel1, T Hsu1, E Tsvetkova1, B Ward3, T Asmis1.
Abstract
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 was held in Montreal, Quebec, 5-7 February. Experts in radiation oncology, medical oncology, surgical oncology, and infectious diseases involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics: ■ Follow-up and survivorship of patients with resected colorectal cancer■ Indications for liver metastasectomy■ Treatment of oligometastases by stereotactic body radiation therapy■ Treatment of borderline resectable and unresectable pancreatic cancer■ Transarterial chemoembolization in hepatocellular carcinoma■ Infectious complications of antineoplastic agents.Entities:
Keywords: Guidelines; biliary tract carcinoma; biologic agents; colorectal cancer; hepatitis B; hepatocellular carcinoma; oligometastasis; pancreatic cancer; stereotactic body radiation therapy; transarterial chemoembolization
Year: 2016 PMID： 28050151 PMCID： PMC5176388 DOI： 10.3747/co.23.3394
Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677